systems of innovation. Limited interaction contributes to explain poor performance in R&D and ultimately, in innovation by …

literature on firm's boundaries and sectoral systems of innovation, we propose industry-specific variables for pharmaceuticals …

This study analyses 1400 research projects of the top 20 R&D-spending pharmaceuticals to identify the determinants of …

position of the US as a locus of innovation in pharmaceuticals has increased over the past decade compared to Europe. All in … European countries. As a whole, Europe is lagging behind in its ability to generate, organise, and sustain innovation processes … in pharmaceuticals: 1) The size and the structure of the biomedical education and research systems; 2) Some basic …

The impact of patent protection on biomedical innovation has been a controversial issue. Although a "medical anti … difficult to predict the impact of patenting on biomedical innovation in developing and least developed countries. This paper … develops a framework of analysis for the impact of patent rights on biomedical innovation in "technology follower" developing …

This study analyses 1400 research projects of the top 20 R&D-spending pharmaceuticals to identify the determinants of …